H Leon Bradlow

Title: H Leon Bradlow: Innovator in Steroid Compound Formulation

Introduction

H Leon Bradlow is a notable inventor based in Queens, NY (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the administration of steroid compounds. His innovative work has the potential to impact various medical conditions, including obesity and diabetes.

Latest Patents

H Leon Bradlow holds 1 patent for his formulation for the administration of steroid compounds. This patent discloses compositions that include at least one 5.beta. steroid and an amorphous cyclodextrin. The methods outlined in his patent aim to treat conditions such as obesity, diabetes syndrome, diabetes-associated hypercorticoidism, and anemic disorders. By administering a composition that includes an obesity-, diabetes-, or anemia antagonistic amount of at least one 5.beta. steroid and an amorphous cyclodextrin, the treatment can be effectively delivered to mammals in need. Additionally, the patent describes methods for treating subjects with conditions responsive to DHEA by administering a combination of 5.beta. steroid and DHEA, optimizing the therapeutic effects while minimizing unwanted hormonal contributions.

Career Highlights

H Leon Bradlow has established himself as a key figure in the pharmaceutical industry through his work at Supergen, Inc. His research and development efforts have focused on creating effective treatments for complex health issues. His innovative approach to steroid formulations showcases his commitment to advancing medical science.

Collaborations

H Leon Bradlow has collaborated with notable colleagues, including Julius A Vida and Elliott L Fineman. These partnerships have contributed to the development of his groundbreaking patent and have fostered a collaborative environment for innovation.

Conclusion

H Leon Bradlow's contributions to the field of steroid compound formulation highlight his role as an influential inventor. His work not only addresses critical health challenges but also paves the way for future advancements in pharmaceutical treatments.